"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>Flavia Napoletano<\/author>Fabrizio Schifano<\/author>John Corkery et al.<\/author><\/authors><\/contributors>The Psychonauts\u2019 World of Cognitive Enhancers<\/title><secondary-title>Frontiers in Psychiatry<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.3389\/fpsyt.2020.546796<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.546796\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chang T<\/author><author>Young RM<\/author><author>Goulet JR et al.<\/author><\/authors><\/contributors><titles><title>Pharmacokinetics of oral pramiracetam in normal volunteers.<\/title><secondary-title>Journal of clinical pharmacology<\/secondary-title><\/titles><dates><year>1985<\/year><\/dates><electronic-resource-num>10.1002\/j.1552-4604.1985.tb02841.x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fang Z<\/author><author>Liu X<\/author><author>Xiao Y et al.<\/author><\/authors><\/contributors><titles><title>[Pharmacokinetics of pramiracetam in animals].<\/title><secondary-title>Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao<\/secondary-title><\/titles><dates><year>1999<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mauri M<\/author><author>Sinforiani E<\/author><author>Reverberi F et al.<\/author><\/authors><\/contributors><titles><title>Pramiracetam effects on scopolamine-induced amnesia in healthy volunteers.<\/title><secondary-title>Archives of gerontology and geriatrics<\/secondary-title><\/titles><dates><year>1994<\/year><\/dates><electronic-resource-num>10.1016\/0167-4943(94)00542-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Butler DE<\/author><author>Nordin IC<\/author><author>L'Italien YJ et al.<\/author><\/authors><\/contributors><titles><title>Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.<\/title><secondary-title>Journal of medicinal chemistry<\/secondary-title><\/titles><dates><year>1984<\/year><\/dates><electronic-resource-num>10.1021\/jm00371a023<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Maresov\u00e1 D<\/author><author>Mares P<\/author><\/authors><\/contributors><titles><title>The action of pramiracetam on consequences of hypobaric hypoxia is only moderate.<\/title><secondary-title>Physiological research<\/secondary-title><\/titles><dates><year>1996<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Murray CL<\/author><author>Fibiger HC<\/author><\/authors><\/contributors><titles><title>The effect of pramiracetam (CI-879) on the acquisition of a radial arm maze task.<\/title><secondary-title>Psychopharmacology<\/secondary-title><\/titles><dates><year>1986<\/year><\/dates><electronic-resource-num>10.1007\/BF00174378<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Claus JJ<\/author><author>Ludwig C<\/author><author>Mohr E et al.<\/author><\/authors><\/contributors><titles><title>Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam.<\/title><secondary-title>Neurology<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1212\/wnl.41.4.570<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>McLean A Jr<\/author><author>Cardenas DD<\/author><author>Burgess D et al.<\/author><\/authors><\/contributors><titles><title>Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia.<\/title><secondary-title>Brain injury<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.3109\/02699059109008110<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Malykh AG<\/author><author>Sadaie MR<\/author><\/authors><\/contributors><titles><title>Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.<\/title><secondary-title>Drugs<\/secondary-title><\/titles><dates><year>2010<\/year><\/dates><electronic-resource-num>10.2165\/11319230-000000000-00000<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Corasaniti MT<\/author><author>Paoletti AM<\/author><author>Palma E et al.<\/author><\/authors><\/contributors><titles><title>Systemic administration of pramiracetam increases nitric oxide synthase activity in the cerebral cortex of the rat.<\/title><secondary-title>Functional neurology<\/secondary-title><\/titles><dates><year>1995<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Auteri A<\/author><author>Blardi P<\/author><author>Celasco G et al.<\/author><\/authors><\/contributors><titles><title>Pharmacokinetics of pramiracetam in healthy volunteers after oral administration.<\/title><secondary-title>International journal of clinical pharmacology research<\/secondary-title><\/titles><dates><year>1992<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ennaceur A<\/author><author>Cavoy A<\/author><author>Costa JC et al.<\/author><\/authors><\/contributors><titles><title>A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam.<\/title><secondary-title>Behavioural brain research<\/secondary-title><\/titles><dates><year>1989<\/year><\/dates><electronic-resource-num>10.1016\/s0166-4328(89)80051-8<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bambagiotti-Alberti M<\/author><author>Bartolucci G<\/author><author>Bruni B et al.<\/author><\/authors><\/contributors><titles><title>Diisoprop-yl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]eth-yl}ammonium hydrogen sulfate.<\/title><secondary-title>Acta crystallographica. Section E, Structure reports online<\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1107\/S1600536808015341<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1107\/s1600536808015341<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gouliaev AH<\/author><author>Senning A<\/author><\/authors><\/contributors><titles><title>Piracetam and other structurally related nootropics.<\/title><secondary-title>Brain research. Brain research reviews<\/secondary-title><\/titles><dates><year>1994<\/year><\/dates><electronic-resource-num>10.1016\/0165-0173(94)90011-6<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Pepeu G<\/author><author>Spignoli G<\/author><\/authors><\/contributors><titles><title>Nootropic drugs and brain cholinergic mechanisms.<\/title><secondary-title>Progress in neuro-psychopharmacology & biological psychiatry<\/secondary-title><\/titles><dates><year>1989<\/year><\/dates><electronic-resource-num>10.1016\/0278-5846(89)90112-7<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"